Core Laboratories (CLB) Getting Somewhat Favorable Media Coverage, Report Finds
Headlines about Core Laboratories (NYSE:CLB) have been trending somewhat positive on Tuesday, AlphaOne reports. The research firm, a service of Accern, identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. AlphaOne ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Core Laboratories earned a media sentiment score of 0.11 on AlphaOne’s scale. AlphaOne also assigned media stories about the oil and gas company an impact score of 85 out of 100, meaning that recent news coverage is very likely to have an effect on the stock’s share price in the near term.
Here are some of the news articles that may have impacted AlphaOne’s rankings:
- Core Laboratories (CLB) Q1 Earnings: Will it Disappoint? – Yahoo Finance (finance.yahoo.com)
- ETFs with exposure to Core Laboratories NV : April 17, 2017 (finance.yahoo.com)
- 3 Things to Watch When Core Laboratories N.V. Reports Earnings (fool.com)
- Core Laboratories (CLB) to Release Earnings on Wednesday (americanbankingnews.com)
Several analysts have weighed in on CLB shares. Zacks Investment Research downgraded shares of Core Laboratories from a “hold” rating to a “sell” rating in a research report on Tuesday, December 20th. Tudor Pickering assumed coverage on shares of Core Laboratories in a research note on Thursday, March 23rd. They set a “hold” rating for the company. Citigroup Inc restated a “neutral” rating and set a $117.00 price objective (down from $119.00) on shares of Core Laboratories in a research note on Saturday, March 11th. Finally, Scotiabank set a $133.00 price objective on shares of Core Laboratories and gave the company a “hold” rating in a research note on Wednesday, March 22nd. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $125.77.
Core Laboratories (NYSE:CLB) traded down 0.80% during trading on Tuesday, hitting $115.90. 388,953 shares of the company traded hands. Core Laboratories has a 52-week low of $96.30 and a 52-week high of $135.49. The company’s 50-day moving average is $113.08 and its 200 day moving average is $113.61. The firm has a market cap of $5.12 billion, a price-to-earnings ratio of 79.38 and a beta of 1.55.
Core Laboratories (NYSE:CLB) last released its earnings results on Wednesday, January 25th. The oil and gas company reported $0.41 EPS for the quarter, meeting analysts’ consensus estimates of $0.41. Core Laboratories had a return on equity of 65.65% and a net margin of 10.74%. The company earned $149.54 million during the quarter, compared to the consensus estimate of $145.78 million. During the same quarter last year, the company earned $0.65 earnings per share. Core Laboratories’s quarterly revenue was down 18.2% compared to the same quarter last year. On average, equities analysts anticipate that Core Laboratories will post $2.09 earnings per share for the current year.
WARNING: This piece was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright legislation. The original version of this piece can be read at http://www.dailypolitical.com/2017/04/18/core-laboratories-clb-getting-somewhat-favorable-media-coverage-report-finds.html.
Core Laboratories Company Profile
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.